| Catalog | name | Description | price | 
|---|---|---|---|
| R-C-1113 | AC710 CAS:1351522-04-7 | AC710 is a potent,orally active,and selective platelet-derived growth factor receptor-family kinase inhibitor with potential anticancer activity. | price> | 
| R-C-1132 | BIBX1382 CAS:196612-93-8 | BIBX 1382 is a cell-permeable pyrimidopyrimidine compound that acts as a potent, reversible,ATP-competitive,and highly selective inhibitor of EGFR. | price> | 
| R-C-1136 | PF-562271 CAS :717907-75-0 | PF-562271 Besylate is the benzenesulfonate salt of PF-562271,which is a potent,ATP-competitive,reversible inhibitor of FAK with IC50 of 1.5 nM,~10-fold less potent for Pyk2 than FAK and>100-fold selectivity against other protein kinases,except for some CDKs. | price> | 
| R-C-1141 | CL-387785 (EKI-785) CAS :194423-06-8 | CL-387785,also known as EKI-785,is a n irreversible inhibitor of EGF-receptor (EGFR)kinase activity in vivo(IC50=250-490 pM).CL-387785 covalently bound to EGF-R.It also specifically inhibited kinase activity of the protein(IC50 =370+/-120 pM),blocked EGF-stimulated autophosphorylation of the receptor in cells(ic50 approximately 5 nM),inhibited cell proliferation(IC50=31-125nM) primarily in a cytostatic manner in cell lines that overexpress EGF-R or c-erbB-2,and profoundly blocked the growth of a tumor that overexpresses EGF-R in nude mice(when given orally at 80 mg/kg/day for 10 days,daily). | price> | 
| R-C-1142 | GW2580 CAS:870483-87-7 | GW2580 is an orally bioavailable and selective inhibitor of c-Fms kinase which completely inhibits human cFMS kinase in vitro at 0.06 μM.GW2580 acts as a competitive inhibitor of ATP binding to the cFMS kinase and inhibits colony-stimulating-factor-1 signaling. | price> | 
| R-C-1153 | SU6656 cas:330161-87-0 | SU6656 is a potent and selective dual inhibitor of Src family kinases and Aurora kinase.SU6656 modulates CTGF(connective tissue growth factor)expression in an ERK-dependent manner.SU6656 induces caspase-independent cell death in FRO anaplastic thyroid carcinoma cells and therapeutic synergy in human synovial sarcoma growth,invasion and angiogenesis in vivo. | price> | 
| R-C-1158 | Pexidartinib (PLX-3397) CAS:1029044-16-3 | Pexidartinib(PLX-3397)is a potent, orally active,selective, and ATP-competitive colony stimulating factor 1 receptor(CSF1R or M-CSFR)and c-Kit inhibitor,with IC50s of 20 and 10 nM respectively.Pexidartinib(PLX-3397) exhibits 10- to 100-fold selectivity for c-Kit and CSF1R over other related kinases.Pexidartinib(PLX-3397)induces cell apoptosis and has anti-tumor activity. | price> | 
| R-C-1171 | LY2874455 CAS:1254473-64-7 | LY2874455 is a pan-FGFR inhibitor with IC50 of 2.8 nM,2.6 nM,6.4 nM,and 6 nM for FGFR1,FGFR2,FGFR3,and FGFR4,respectively,and also inhibits VEGFR2 activity with IC50 of 7 nM. | price> | 
| R-C-1173 | TP-0903 CAS:1341200-45-0 | TP-0903 is a potent and selective AXL Inhibitor with IC50 of 27 nM.TP-0903 is highly effective in inducing apoptosis. | price> | 
| R-C-1211 | SU-5614 CAS:1055412-47-9 | SU5614 is a potent and selective FLT3 inhibitor.SU5614 reverts the antiapoptotic and pro-proliferative activity of FLT3 ligand(FL)in FL-dependent cells. | price> | 

Items-$0.00

Email:
Tel.:
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

